Shuduo Xie
Sir Run Run Shaw Hospital
Hangzhou, 310016, China
Hangzhou, 310016, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
A retrospective comparative study on the diagnostic efficacy and the complications: between CassiII rotational core biopsy and core needle biopsy.
Journal: Frontiers in oncology
Published: December 05, 2022
Corrigendum: STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1.
Journal: Frontiers in oncology
Published: February 21, 2022
STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1.
Journal: Frontiers in oncology
Published: April 20, 2021
Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 09, 2021
Establishment and Characterization of a HER2-Positive Cell Line Derived From the Pleural Effusion of a Drug-Resistant Breast Cancer Patient.
Journal: Frontiers in cell and developmental biology
Published: March 15, 2021
Contrast of Mastoscopic and Conventional Axillary Lymph Node Dissection of Patients With Breast Cancer: Meta-Analysis.
Journal: Cancer control : journal of the Moffitt Cancer Center
Published: July 01, 2020
FKBP4 is a malignant indicator in luminal A subtype of breast cancer.
Journal: Journal of Cancer
Published: October 08, 2019
H19/let‑7/Lin28 ceRNA network mediates autophagy inhibiting epithelial‑mesenchymal transition in breast cancer.
Journal: International journal of oncology
Published: September 07, 2019
Evaluation of the diagnostic value of circulating tumor cells with CytoSorter® CTC capture system in patients with breast cancer.
Journal: Cancer medicine
Published: June 05, 2019
The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy.
Journal: Journal of hematology & oncology
Published: January 03, 2019
Establishment and characterization of three stable Basal/HER2-positive breast cancer cell lines derived from Chinese breast carcinoma with identical missense mutations in the DNA-binding domain of TP53.
Journal: Cancer cell international
Published: March 29, 2018
Last Updated: 09/26/2026